These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 28903781)

  • 1. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis.
    Sheng L; Stewart T; Yang D; Thorland E; Soltys D; Aro P; Khrisat T; Xie Z; Li N; Liu Z; Tian C; Bercow M; Matsumoto J; Zabetian CP; Peskind E; Quinn JF; Shi M; Zhang J
    Acta Neuropathol Commun; 2020 Jul; 8(1):102. PubMed ID: 32641150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving insights into erythrocytes in synucleinopathies.
    Yang Y; Nie X; Wang Y; Sun J; Gao X; Zhang J
    Trends Neurosci; 2024 Sep; 47(9):693-707. PubMed ID: 39043489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.
    Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J
    J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
    Matsumoto J; Stewart T; Banks WA; Zhang J
    Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein.
    Amagai R; Otomo R; Yoshioka S; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
    J Biochem; 2024 May; 175(6):649-658. PubMed ID: 38308089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells.
    Gustafsson G; Lööv C; Persson E; Lázaro DF; Takeda S; Bergström J; Erlandsson A; Sehlin D; Balaj L; György B; Hallbeck M; Outeiro TF; Breakefield XO; Hyman BT; Ingelsson M
    Cell Mol Neurobiol; 2018 Nov; 38(8):1539-1550. PubMed ID: 30288631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
    Zhang S; Eitan E; Wu TY; Mattson MP
    Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from patients with Parkinson's disease are pathological in mice.
    Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
    J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha synuclein is transported into and out of the brain by the blood-brain barrier.
    Sui YT; Bullock KM; Erickson MA; Zhang J; Banks WA
    Peptides; 2014 Dec; 62():197-202. PubMed ID: 25278492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized α-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers.
    Alam P; Holst MR; Lauritsen L; Nielsen J; Nielsen SSE; Jensen PH; Brewer JR; Otzen DE; Nielsen MS
    Fluids Barriers CNS; 2022 May; 19(1):37. PubMed ID: 35637478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
    Miao Y; Meng H
    Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of the erythrocyte miR-451a in brain extracellular vesicles following impairment of the blood-brain barrier.
    Koopaei NN; Chowdhury EA; Jiang J; Noorani B; da Silva L; Bulut G; Hakimjavadi H; Chamala S; Bickel U; Schmittgen TD
    Neurosci Lett; 2021 Apr; 751():135829. PubMed ID: 33727125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
    Herman S; Djaldetti R; Mollenhauer B; Offen D
    Brain; 2023 Jan; 146(1):209-224. PubMed ID: 35881523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier
    Morad G; Carman CV; Hagedorn EJ; Perlin JR; Zon LI; Mustafaoglu N; Park TE; Ingber DE; Daisy CC; Moses MA
    ACS Nano; 2019 Dec; 13(12):13853-13865. PubMed ID: 31479239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
    Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
    Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Alpha-Synuclein is Essential for the Transfer of Pathology by Exosome-Enriched Extracellular Vesicles, Following Inoculation with Preformed Fibrils in vivo.
    Melachroinou K; Divolis G; Tsafaras G; Karampetsou M; Fortis S; Stratoulias Y; Papadopoulou G; Kriebardis AG; Samiotaki M; Vekrellis K
    Aging Dis; 2024 Apr; 15(2):869-892. PubMed ID: 37548944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.